Cancer Predisposition Syndromes Flashcards
11p15
abnormalities
- BWS: Methylation defects or uniparental disomy of 11p15
- 10% lifetime risk of several cancers, including
1. Wilms tumor (43%)
2. Hepatoblastoma (20%)
3. Adrenal cortical carcinoma (7%)
4. Neuroblastoma
5. RMS
DICER1
- DICER1 syndrome: Mutations in DICER1 disrupt the processing of miRNAs and predispose to:
1. PPB
2. Thyroid/multinodular goiter
3. Cystic nephroma
4. Botryoid RMS
5. Sertoli-Leydig sex cord-stromal tumors
Ciliary body medulloepithelioma
RB1
- Inherited Retinoblastoma: Associated with:
1. Osteosarcoma
(25-40%; radiation!)
2. Pineoblastoma (trilateral retinoblastoma)
3. Soft tissue sarcomas
(10-15%; leiomyosarcoma > fibrosarcoma > NRSTS > RMS)
4. Melanoma
(15-20%)
TP53
- Li-Fraumeni syndrome: Very high risk of cancer:
1. Sarcomas (soft tissue and osteosarcoma)
2. Malignant glioma
3. Low-hypodiploid ALL (31-39 chromosomes)
4. Choroid plexus carcinoma
5. Adrenocortical carcinoma
TSC1/TSC2
- Tuberous sclerosis: Mutations in TSC1/2
- Hypopigmented lesions (“ash-leaf” macules), facial angiofibromas, benign hamartomas (“tubers”) throughout the body, subependymal giant cell astrocytomas
(MTOR inhibitor), renal cell carcinoma.
ATM
- Ataxia-telangiectasia syndrome: ATM is vital in DNA repair
- Characterized by:
1. Ataxia and chorea when young
2. Telangiectasia later in life
3. Immunodeficiency and infections
4. Risk of developing leukemia and lymphoma
5. Sensitivity to ionizing radiation
PTCH1
- Gorlin syndrome: Aka. nevoid basal cell carcinoma syndrome
- Associated with:
1. Basal cell carcinoma
2. 2. Benign jaw tumors (keratocystic odontogenic tumors)
3. An increased incidence of medulloblastoma (SHH subtype, as PTCH1 is in the SHH pathway)
PTEN
KLLN
SDHB
SDHD
- Cowden syndrome: Characterized by
1. Benign hamartomas
2. Predisposition to breast and endometrial cancer (85%)
3. Thyroid cancer (35%)
4. Papillary RCC (35%) - Most common mutations in PTEN
PTPN11
SOS1
RAF1
RIT1
- Noonan syndrome: Affect the RAS/MAPK pathway
- Characterized by
1. Facial dysmorphism
2. Short stature
3. Congenital heart disease (e.g., pulmonary stenosis)
4. Increased risk of JMML, neuroblastoma, and ERMS
RECQL4
- Rothmund-Thomson syndrome: Biallelic mutations
- Significant predispo to osteosarcoma (30% incidence)
- Associated with facial/extremity rash in infancy, sparse scalp hair, juvenile-onset cataracts, musculoskeletal defects
RET2
- Multiple endocrine neoplasia type 2 (MEN2): Both type 2A and 2B have an increased risk of medullary thyroid carcinoma and pheochromocytoma
- MEN 2A also involves an increased risk for parathyroid adenoma
- MEN 2B is associated with mucosal neuromas and a marfanoid habitus
RUNX1 (AML1)
- Familial platelet disorder with predisposition to AML: Have qualitative and quantitative platelet defects
VHL
- von Hippel-Lindau disease: Autosomal dominant
- Associated with benign (hemangioblastomas in the CNS) and cancerous (renal cell carcinoma, pheochromocytoma) tumors
- Tumors occurrence in young adulthood
CXCR4
- WHIM syndrome: Gain of function mutation
- Characterized by warts, hypogammaglobulinemia, infections, and myelokathexis (neutrophils stuck in the bone marrow)
GATA2
- MonoMAC syndrome: Monocytopenia, B and NK cytopenia, and atypical mycobacterial infection
- Familial AML
- Emberger syndrome: Lymphedema, warts, and predisposition to AML/MDS
HPS2 (aka AP3B1)
- Hermansky-Pudlack syndrome type 2: Autosomal recessive
- Characterized by:
1. Albinism
2. Neutropenia and immune deficiency
3. Platelet defects (dense granules)
4. Propensity to develop HLH
5. Pulmonary fibrosis
LYST
- Chediak Higashi: Autosomal recessive mutations
- Characterized by:
1. Albinism with giant granules in myeloid cells
2. Platelet defects (dense granules)
3. Propensity to develop HLH
RAB27A
- Griscelli syndrome type 2: Autosomal recessive
- Characterized by partial albinism (silver hair) and a propensity to HLH
SH2D1A
XIAP
- XLPS: Associated with
1. Immunodeficiency (B cells present but dys-/hypogammaglobulinemia)
2. Fulminant infections with EBV
STAT3
TYK2
DOCK
- Job’s syndrome (aka. Hyper-IgE syndrome): autosomal dominant (STAT3) or recessive (TYK2, DOCK8) defects in JAK-STAT signaling
- Associated with defective
1. Immunodeficiency (neutrophil chemotaxis, T cell function, very elevated IgE, and eosinophilia)
2. Coarse facies
3. Severe skin, sinus, and pulmonary infections - Patients require antimicrobial prophylaxis
ALAS2
- X-linked sideroblastic anemia: ALAS2 encodes for the erythroid ALA-synthase that is part of the heme production synthesis
- Results in accumulation of erythroblasts with excess iron
- Visualization with Prussian Blue stain in the bone marrow
- Peripheral blood has two RBC populations (normocytic and microcytic)
CYB5R1-4
- Cytochrome b5 reductase deficiency: Autosomal recessive methemoglobinemia
- Type 1: Only RBCs are deficient in cytochrome b5 reductase resulting in lifelong
methemoglobinemia, cyanosis, physiologic adaptation - Type 2: All cells are deficient resulting in Type 1 symptoms, neurological complications, and death within the first year of life
F8 Inv22
- Hemophilia A: Factor VIII intron 22 inversion with truncated protein
- Causes severe hemophilia A in 50% of patients
GPI Deficiency
- Glucose phosphate isomerase deficiency: 2nd most common hereditary nonspherocytic hemolytic anemia
- Enzymopathy affecting anaerobic glycolysis and increased splenic clearance of RBCs
- Associated with neurologic impairment
HBM
- Inherited methemoglobinemia (α58 His→Tyr): Hgb variant with ferric iron
- Patients are asymptomatic despite high levels of methemoglobin
P5N
- Pyrimidine 5’-nucleotidase deficiency: Autosomal recessive non-spherocytic hemolytic anemia
- Characterized by basophilic stippling
- Of note, lead toxicity inhibits pyrimidine 5’-nucleotidase and exhibits basophilic stippling
PKLR
- Pyruvate kinase deficiency: Most common hereditary non-spherocytic hemolytic anemia
- Enzymopathy affecting anaerobic glycolysis and splenic clearance of RBCs
TMPRSS6
- Iron-refractory iron deficiency anemia (IRIDA): Autosomal recessive
- Increased expression of the iron regulatory hormone hepcidin, which results in iron deficiency anemia that is refractory to oral iron and only partly responsive to
parenteral iron
Adrenocortical Carcinoma
Li Fraumeni - TP53
Beckwith-Widemann - 11p15.5
Choroid Plexus Carcinoma, Anaplastic RMS, Hypodiploid ALL
Li Fraumeni - TP53
Desmoid Tumor
FAP - APC
Hepatoblastoma
Beckwith-Wideman - 11p15.5
FAP - APC
JMML
NF1 - NF1
Noonan - PTPN11, KRAS
Medullary Thyroid Carcinoma
MEN 2A/B - RET
Neuroblastoma
Familial - ALK
Congenital central Hypovent synd - PHOX2B
Pleuropulmonary Blastoma
DICER1 Synd - DICER1
Pheochromocytoma/Paraganglioma
Pheo/paraganglioma syndrome - SDH
NF1 - NF1
MEN2 A/B - RET
von Hipple Lindau - VHL
Renal Cell Carcinoma
VHL - VHL
Rhabdoid Tumor, ATRT
Rhabdoid Tumor Syndrome - SMARCB1
Wilms Tumor
Beckwith-Wideman - 11p15.5
WAGR/Denys-Drash - WT1
Familial AML
CEBPA
alpha 1 Antitrypsin Deficiency
SERPINA1 - Hepatocellular Carcinoma
Bloom Syndrome
BLM - ALL/AML/Wilms
Bohring-Opitz Syndrome
ASXL1 - Wilms
CLOVES
PIK3CA - Wilms
CAMT
cMPL - AML
Congenital Hypoventilation Syndrome
PHOX2B - Neuroblastoma
Constitutional Mismatch Repair Def
PMS2, MLH1, MSH2/6 - ALL/High Grade Glioma/Early Colon Cancer
Costello
HRAS - Rhabdomyosarcoma
Cowden
PTEN - Papillary thyroid carcinoma
Denys Drash
WT1
Diamond- Blackfan
RPS19 - AML/MDS, ALL
Frasier Syndrome
WT1 - Wilms
Glycogen Storage Disease
Hepatoblastoma, Hepatocellular Carcinoma
Gonadal Dysgenesis
46XY Swyer, 45XO Turner - Germ Cell Tumors
Gorlin
PTCH1, SUFU - Basal cell carcinoma, Rhabdo, Medulloblastoma (SHH)
Klinefelter Synd
47 XXY - ALL, Germ Cell Tumor
Hereditary Leiomyomatosis
FH - Renal Cell Carcinoma
Li Fraumeni
Adrenocortical Carcinoma
ERMS (anaplastic)
Osteosarcoma
Neuroblastoma
Choroid Plexus Carcinoma
Malignant Glioma
Hypodiploid ALL
AML
MEN -1
MEN1 - Pancreatic neuroendocrine, pituitary, parathyroid, adrenal cortical carcinoma
MEN-2A
RET - Medullary thyroid cancer
MEN-2B
RET - Medullary thyroid cancer, pheochromocytoma, paraganglioma
MEN4
CDKN1B - Pituitary adenoma, parathyroid tumor, GU tumors
Familial Neuroblastoma
ALK, RASopathies, PHOX2B
NF1
Optic glioma, MPNST, Pheochromocytoma, Rhabdomyosarcoma, GIST, Neuroblastoma, JMML, Early breast cancer, Adrenocortical carcinoma
NF2
NF2 - Acoustic schwannomas, meningiomas, astrocytoma, ependymoma
Nijmen Breakage Syndrome
NBN - ALL
Noonan
KRAS/PTPN11/CBL - JMML, ALL, Rhabdo, Neuroblastoma
Perlman
DIS3L2 - Wilms, Nephroblastoma
Peutz-Jegher
STK11 - Sex cord tumor w/ annular tubules
Pheochromocytoma/Paraganglioma
SDHx - Pheo, paraganglioma, renal cell carcinoma
Familial Platelet Disorder
RUNX1 - MDS/AML (Mono 7), anticipation
Heritable Retinoblastoma
RB - Retinoblastoma, Pineoblastoma, Osteosarcoma
Rhabdoid Tumor
SMARCB1 - Renal Rhabdoid, ATRT, Schwannomatosis
Rhabdoid Tumor Type 2
Small cell carcinoma of ovary (hypercalcemic), ATRT
Rothmund-Thompson
RECQL4 - Osteosarcoma
Schwachman - Diamond
SBDS, SBDSP++ - MDS/AML
Severe Congenital Neutropenia
ELANE, SCN7+ - MDS/AML (-7)
Simpson - Golabi - Behmel
GPC3 - Wilms
Sotos
NSD1 - Wilms
Thrombocytopenia 2
ANKRD26 - AML
Thrombocytopenia 5
ETV6 - Pre-B all (Hyperdiploid), MDS/AML
Tuberous Sclerosis
TSC1/2 - Subependymal giant cell astrocytoma (SEGA), Renal cell carcinoma
WAGR
11p- - Wilms
Risks of Germline TP53
75% - Anaplastic RMS, SHH Medulloblastoma
50% - ACC, Choroid plexus carcinoma, hypodiploid ALL
10% - Early onset breast cancer w/o BRCA 1/2